Skip to main content
BioCentury Innovations (formerly SciBX)
Feature Story

Public Funding Notebook: Small change for NIH

Public Funding Notebook 4Q14

By Mark Zipkin, Staff Writer

NIH has released data on grants awarded in FY14, and the numbers suggest that in a year in which the private sector saw money start to flow freely with a surge of biotech IPOs, it was pretty much business as usual for public funding in biomedical research.

The trends of recent years remain largely the same. Research project grant applications remain high, just shy of their record FY12 numbers, and up 28% over a decade ago. Less than a quarter of applications were funded, although total award numbers are up 11% from FY13.

Read Article | PDF
  • THE DISTILLERY brings you this week's most essential scientific findings in therapeutics, distilled by Innovations editors from a weekly review of more than 400 papers in 41 of the highest-impact journals in the fields of biotechnology, the life sciences and chemistry. The Distillery goes beyond the abstracts to explain the commercial relevance of featured research, including licensing status and companies working in the field, where applicable.

    This week in therapeutics includes important research findings on targets and compounds, grouped first by disease class and then alphabetically by indication.

    This week in techniques includes findings about research tools, disease models and manufacturing processes that have the potential to enable or improve all stages of drug discovery and development.

Subscribe Now
Free Trial